Cargando…
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland
Limited data exist on SARS-CoV-2 infection rates across sectors and occupations, hindering our ability to make rational policy, including vaccination prioritization, to protect workers and limit SARS-CoV-2 spread. Here, we present results from our SEROCoV-WORK + study, a serosurvey of workers recrui...
Autores principales: | Stringhini, Silvia, Zaballa, María-Eugenia, Pullen, Nick, de Mestral, Carlos, Perez-Saez, Javier, Dumont, Roxane, Picazio, Attilio, Pennacchio, Francesco, Dibner, Yaron, Yerly, Sabine, Baysson, Helene, Vuilleumier, Nicolas, Balavoine, Jean-François, Bachmann, Delphine, Trono, Didier, Pittet, Didier, Chappuis, François, Kherad, Omar, Kaiser, Laurent, Azman, Andrew S., Guessous, Idris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187639/ https://www.ncbi.nlm.nih.gov/pubmed/34103517 http://dx.doi.org/10.1038/s41467-021-23796-4 |
Ejemplares similares
-
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021
por: Stringhini, Silvia, et al.
Publicado: (2021) -
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland
por: Baysson, Helene, et al.
Publicado: (2022) -
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study
por: Zaballa, María-Eugenia, et al.
Publicado: (2022) -
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021) -
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance
por: Perez-Saez, Javier, et al.
Publicado: (2021)